Adaptimmune Limited

Where the EU money came from

Funding by EU programme. Amounts are Adaptimmune Limited's own share of each project, not the project's full budget.

Projects

1 EU-funded project, newest first. Each links to the official record.

• ATTACKPartner

  Adoptive engineered T cell Trials to Achieve Cancer Killing

  FP7 (2007 to 2013) · 2012–2017 · Project on CORDIS ↗

  €306ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

• Institut National de la Sante et de la Recherche MedicaleFrance · 1 shared project
• Karolinska InstitutetSweden · 1 shared project
• The University of ManchesterUnited Kingdom · 1 shared project
• Erasmus Universitair Medisch Centrum RotterdamNetherlands · 1 shared project
• University College LondonUnited Kingdom · 1 shared project
• Stichting Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek ZiekenhuisNetherlands · 1 shared project
• Ospedale San Raffaele SRLItaly · 1 shared project
• Region StockholmSweden · 1 shared project
• Fondazione Centro San RaffaeleItaly · 1 shared project
• Miltenyi Biotec GmbHGermany · 1 shared project
• University College London Hospitalsnhs Foundation TrustUnited Kingdom · 1 shared project
• Amsterdam Biotherapeutics UnitNetherlands · 1 shared project
• Instil Bio (UK) LimitedUnited Kingdom · 1 shared project
• The Christie Nhs Foundation TrustUnited Kingdom · 1 shared project
• Royal Free London Nhs Foundation TrustUnited Kingdom · 1 shared project

Fields it works in

Research fields recorded on its Horizon projects.

• cells technologies
• melanoma
• nucleic acids